D
Cullinan Therapeutics, Inc. CGEM
$8.74 -$0.33-3.64% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income -178.74M -167.38M -143.54M -142.16M -132.35M
Total Depreciation and Amortization 306.00K 306.00K 306.00K 310.00K 314.00K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 24.50M 22.16M 18.33M 18.97M 17.93M
Change in Net Operating Assets 3.72M -389.00K -1.90M -3.92M -7.42M
Cash from Operations -150.21M -145.30M -126.81M -126.81M -121.53M
Capital Expenditure -- -- 0.00 0.00 -49.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -112.47M -136.31M -100.81M -163.64M 33.63M
Cash from Investing -112.47M -136.31M -100.81M -163.64M 33.58M
Total Debt Issued -- -- 0.00 0.00 0.00
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 269.55M 270.64M 269.30M 267.43M 40.01M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -4.45M -4.45M -4.45M -3.79M 36.00K
Cash from Financing 265.10M 266.19M 264.85M 263.64M 40.05M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 2.43M -15.43M 37.24M -26.81M -47.90M